28 Feb
US FDA accepts Arena’s weight loss drug lorcaserin NDA filing (PharmaBiz)
Posted in Weight Management on 28.02.10 by Merlyn |
Arena Pharmaceuticals, Inc announced that its New Drug Application (NDA) for lorcaserin, Arena’s internally discovered and developed drug candidate for weight management, including weight loss and maintenance of weight loss, has been accepted for filing by the US Food and Drug Administration (FDA). Arena submitted the lorcaserin NDA on December 22, 2009, and expects to learn the Prescription …
Comments Off